drugset / Trial / NCT06690138
A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
This is a Phase 1, open-label, two-period, fixed sequence drug-drug interaction study to evaluate the impact of multiple doses of Itraconazole on the pharmacokinetics (PK) and safety of Divarasib in healthy participants.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2025-02-11
- Completion
- 2025-02-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Divarasib | Small molecule | — | Oral |
| Subject | Itraconazole | Small molecule | — | — |
Indications
No indication recorded.